Michaela Levin
Vermogen: 61 500 $ op 30-09-2026
Vermogen: 61 500 $ op 30-09-2026
Michaela Levin is currently Chief Business Officer at Acrivon Therapeutics, Inc. Formerly, Dr. Levin was Vice President-Business Development at Recursion Pharmaceuticals, Inc. Dr. Levin earned a doctorate from the University of Virginia.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-08-2026 | 30.000 ( 0,07% ) | 61 500 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 31-08-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau